Cooper Companies Inc (NYSE:COO) Stake Lifted by Semmax Financial Advisors Inc.

Share on StockTwits

Semmax Financial Advisors Inc. increased its stake in shares of Cooper Companies Inc (NYSE:COO) by 101.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,236 shares of the medical device company’s stock after buying an additional 623 shares during the quarter. Semmax Financial Advisors Inc.’s holdings in Cooper Companies were worth $416,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. BlackRock Inc. grew its stake in Cooper Companies by 1.4% during the 1st quarter. BlackRock Inc. now owns 3,784,211 shares of the medical device company’s stock worth $1,120,769,000 after buying an additional 51,482 shares during the last quarter. Janus Henderson Group PLC grew its stake in Cooper Companies by 4.1% during the 1st quarter. Janus Henderson Group PLC now owns 2,834,318 shares of the medical device company’s stock worth $839,449,000 after buying an additional 112,906 shares during the last quarter. Veritas Asset Management LLP grew its stake in shares of Cooper Companies by 77.8% in the first quarter. Veritas Asset Management LLP now owns 981,302 shares of the medical device company’s stock worth $290,632,000 after purchasing an additional 429,340 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Cooper Companies by 9.7% in the fourth quarter. Geode Capital Management LLC now owns 721,796 shares of the medical device company’s stock worth $183,414,000 after purchasing an additional 63,889 shares in the last quarter. Finally, Northern Trust Corp grew its stake in shares of Cooper Companies by 2.4% in the first quarter. Northern Trust Corp now owns 602,699 shares of the medical device company’s stock worth $178,501,000 after purchasing an additional 14,293 shares in the last quarter. Hedge funds and other institutional investors own 96.59% of the company’s stock.

Shares of Cooper Companies stock traded down $8.15 during trading on Friday, hitting $321.67. The stock had a trading volume of 243,461 shares, compared to its average volume of 251,564. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.21 and a quick ratio of 0.68. The firm has a market cap of $16.32 billion, a P/E ratio of 27.97, a PEG ratio of 2.50 and a beta of 0.90. The business has a fifty day moving average of $333.71 and a two-hundred day moving average of $306.05. Cooper Companies Inc has a fifty-two week low of $228.65 and a fifty-two week high of $344.32.

Cooper Companies (NYSE:COO) last announced its quarterly earnings data on Thursday, May 30th. The medical device company reported $2.94 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.76 by $0.18. The business had revenue of $654.30 million during the quarter, compared to analyst estimates of $655.00 million. Cooper Companies had a return on equity of 17.25% and a net margin of 16.46%. The company’s revenue was up 3.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.86 earnings per share. As a group, research analysts forecast that Cooper Companies Inc will post 12.28 earnings per share for the current year.

The company also recently disclosed a Semi-Annual dividend, which was paid on Wednesday, August 7th. Stockholders of record on Tuesday, July 23rd were issued a $0.03 dividend. The ex-dividend date was Monday, July 22nd. Cooper Companies’s dividend payout ratio (DPR) is 0.52%.

Several research analysts have recently issued reports on COO shares. Piper Jaffray Companies increased their price target on Cooper Companies from $330.00 to $360.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 13th. Raymond James increased their price target on Cooper Companies from $325.00 to $364.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 2nd. Wells Fargo & Co increased their price target on Cooper Companies from $356.00 to $365.00 and gave the stock an “outperform” rating in a research note on Thursday, August 8th. Zacks Investment Research raised Cooper Companies from a “hold” rating to a “buy” rating and set a $336.00 price target for the company in a research note on Friday, June 7th. Finally, KeyCorp increased their price target on Cooper Companies from $314.00 to $351.00 and gave the stock an “overweight” rating in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and eleven have issued a buy rating to the company’s stock. Cooper Companies presently has a consensus rating of “Buy” and a consensus price target of $326.27.

In other news, Director Gary S. Petersmeyer sold 355 shares of the company’s stock in a transaction on Monday, June 17th. The stock was sold at an average price of $323.92, for a total value of $114,991.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Randal Golden sold 1,154 shares of the company’s stock in a transaction on Wednesday, June 19th. The shares were sold at an average price of $328.16, for a total value of $378,696.64. Following the completion of the sale, the vice president now owns 1,148 shares of the company’s stock, valued at approximately $376,727.68. The disclosure for this sale can be found here. In the last 90 days, insiders sold 77,678 shares of company stock valued at $25,063,536. Insiders own 1.70% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Featured Story: Understanding Compound Annual Growth Rate (CAGR)

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply